Volume 18 Issue 1 March 2009
| Original Research |
The Asthma Control TestTM (ACT) as a predictor of GINA guideline-defined asthma control: analysis of a multinational cross-sectional survey
Pages 41-49
*Mike Thomasa, Stephen Kayb, James Pikeb, Angela Williamsc, Jacqueline R Carranza Rosenzweigc, Elizabeth V Hillyerd, David Pricea
a Centre of Academic Primary Care, University of Aberdeen, Scotland, UK
b Adelphi Real World Products, Bollington, UK
c Global Health Outcomes, GlaxoSmithKline R&D, Research Triangle Park, North Carolina, USA
d Respiratory Research Ltd, Norwich, UK
Received 28 May 2008 • Accepted 28 November 2008 • Online 24 February 2009
Abstract
AIMS: To evaluate whether the Asthma Control TestTM (ACT) score is predictive of Global Initiative for Asthma (GINA) guideline-defined classification levels of asthma control. The ACT is a validated, 5-item, patient-completed measure of asthma control with a recall period of four weeks. METHODS: Cross-sectional survey comparing ACT score and GINA classification of asthma control among 2949 patients attending primary care physicians and specialists in France, Germany, Italy, Spain, the UK, and the USA. RESULTS: The area under the receiver operating characteristics curve for ACT score predicting GINA control was 0.84 (95% CI 0.82–0.85). An ACT score of <19 (not well-controlled asthma) correctly predicted GINA-defined partly controlled/uncontrolled asthma 94% of the time, while an ACT score of >20 predicted GINA-defined controlled asthma 51% of the time, with kappa statistic of 0.42, representing moderate agreement. CONCLUSIONS: An ACT score <19 is useful for identifying patients with poorly controlled asthma as defined by GINA.
Cite as: Thomas M, Kay S, Pike J, Williams A, Rosenzweig JRC, Hillyer EV, Price D. The Asthma Control TestTM (ACT) as a predictor of GINA guideline-defined asthma control: analysis of a multinational cross-sectional survey. Prim Care Respir J 2009;18(1):41-49. DOI: http://dx.doi.org/10.4104/pcrj.2009.00010
Keywords
Asthma, Asthma Control Test, control, GINA, exacerbations, multinational survey, patient-completed outcome assessment, Europe, United States
* Corresponding author. Mike Thomas Tel: +44 (0)23 80 241050 Fax: +44 (0)23 80 241050 Email: D.M.Thomas@soton.ac.uk
